Allergy Relief (levocetirizine dihydrochloride) NDC 21130-732

Product information

Brand name (proprietary)

Allergy Relief

Generic name (nonproprietary)

levocetirizine dihydrochloride

Active ingredients

Levocetirizine dihydrochloride — 5 mg/1

Dosage form

Tablet, Coated

Route

Oral

Labeler

Albertsons Companies

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 210375

Marketing start

Jun 30, 2018

Listing expires

Dec 31, 2027

Other FDA classes

Histamine H1 Receptor Antagonists (Mechanism)

Identifiers

Product ID 21130-732_f2d46324-71b9-4ac8-839d-bb2fa3c04a48SPL ID f2d46324-71b9-4ac8-839d-bb2fa3c04a48SPL set ID e1a6932b-d076-6573-5b88-7b06c3a91681RxCUI 855172UNII SOD6A38AGA

Pharmacologic class

Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N421130073210 followed by a unit qualifier and the quantity Copy

Package 21130-0732-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 210375

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.